Clinical implications of cytogenetic and molecular aberrations in multiple myeloma
S Goldman-Mazur, DH Vesole… - Acta Haematologica …, 2021 - journals.viamedica.pl
Multiple myeloma (MM) is an incurable haematological malignancy affecting approximately
7: 100,000 people. Monoclonal gammopathy of undetermined significance (MGUS) and …
7: 100,000 people. Monoclonal gammopathy of undetermined significance (MGUS) and …
[HTML][HTML] Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations
P Kadam Amare, S Nikalje Khasnis, P Hande… - … and Genome Research, 2022 - karger.com
Multiple myeloma (MM) is a genetically complex and heterogeneous neoplasm in which
cytogenetics is a major factor playing an important role in the risk stratification of disease …
cytogenetics is a major factor playing an important role in the risk stratification of disease …
[HTML][HTML] A diagnostic approach to detect cytogenetic heterogeneity and its prognostic significance in multiple myeloma
AA Kalal, M Arumugam, VV Shetty… - Journal of Taibah …, 2023 - ncbi.nlm.nih.gov
Objective Multiple myeloma (MM) is a hematological disorder involving the uncontrolled
proliferation of clonal plasma cells and its accumulation in the bone marrow. This study …
proliferation of clonal plasma cells and its accumulation in the bone marrow. This study …
Correlations between apparent diffusion coefficient values of WB-DWI and clinical parameters in multiple myeloma
B Zhang, B Bian, Z Zhao, F Lin, Z Zhu, M Lou - BMC Medical Imaging, 2021 - Springer
Background Whole-body diffusion-weighted imaging (WB-DWI) is a method for evaluating
bone marrow infiltration in multiple myeloma (MM). This study seeks to elucidate the …
bone marrow infiltration in multiple myeloma (MM). This study seeks to elucidate the …
Valor pronóstico de las anomalías genéticas en mieloma múltiple
F Stella, LG Guash, E Pedrazzini… - Revista …, 2021 - revistahematologia.com.ar
El mieloma múltiple (MM) es una neoplasia B post centro germinal caracterizada por la
proliferación clonal de células plasmáticas en la médula ósea y la detección de una …
proliferación clonal de células plasmáticas en la médula ósea y la detección de una …
Biological implications of deletion p53 by fluorescence in situ hybridization in multiple myeloma
VV Shetty, M Arumugam, RA Shetty… - Biomedical and …, 2022 - journals.lww.com
Background: Multiple myeloma (MM) is a clonal plasma cell disorder characterized by
heterogeneous complex genetic abnormalities. Due to the low proliferative index of plasma …
heterogeneous complex genetic abnormalities. Due to the low proliferative index of plasma …
Natural history and prognostic factors at first relapse in multiple myeloma
The prognosis of multiple myeloma has considerably improved due to the introduction of
novel agents in the upfront setting. However, the great majority of patients ultimately relapse …
novel agents in the upfront setting. However, the great majority of patients ultimately relapse …
[PDF][PDF] PROGNOSTISCHE WAARDE VAN UITGEBREIDE KARYOTYPERING MIDDELS COPY NUMBER VARIATION (CNV) SEQUENCING BIJ NIEUW …
K Maes - libstore.ugent.be
Multipel myeloom (MM) is een klonale B-cel neoplasie welke voortkomt uit terminaal
gedifferentieerde plasmacellen (1). Het is de tweede meest voorkomende hematologische …
gedifferentieerde plasmacellen (1). Het is de tweede meest voorkomende hematologische …